Clinical Trial Update: Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on prevention of paclitaxel-induced peripheral neuropathy in breast cancer patients; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Future University in Egypt | Conditions: Peripheral Neuropathy Due to Chemotherapy | Phase 2 | Status: COMPLETED